Zhirong Mou
Winnipeg, MB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Correction: Long pentraxin 3 (PTX3) regulates IL-17A-mediated secondary immunity to Leishmania major infection in mice.
Journal: Frontiers in immunology
Published: February 26, 2026
Long pentraxin 3 (PTX3) regulates IL-17A-mediated immunity to Leishmania major infection in mice.
Journal: Frontiers in immunology
Published: November 05, 2025
IL-12 mRNA-LNP promotes dermal resident memory CD4+ T cell development.
Journal: NPJ vaccines
Published: March 31, 2025
Leishmania major Dihydrolipoyl dehydrogenase (DLD) is a key metabolic enzyme that drives parasite proliferation, pathology and host immune response.
Journal: PLoS pathogens
Published: June 13, 2024
Antigen recognition reinforces regulatory T cell mediated Leishmania major persistence.
Journal: Nature communications
Published: June 13, 2023
Protective CD4+ Th1 cell-mediated immunity is reliant upon execution of effector function prior to the establishment of the pathogen niche.
Journal: PLoS pathogens
Published: May 11, 2021
The Phosphoenolpyruvate Carboxykinase Is a Key Metabolic Enzyme and Critical Virulence Factor of Leishmania major.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 07, 2020
Semaphorin 3E Promotes Susceptibility to Leishmania major Infection in Mice by Suppressing CD4+ Th1 Cell Response.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 06, 2020
Identification of a Protective Leishmania Antigen Dihydrolipoyl Dehydrogenase and Its Responding CD4+ T Cells at Clonal Level.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 27, 2020
Last Updated: 09/26/2026